Clinical Trial Update: A Safety and Efficacy Study of Naltrexone SR/Bupropion SR and Placebo in Overweight and Obese Subjects Participating in an Intensive Behavior Modification Program [Phase 3]

View source ↗

Summary

Phase 3 safety and efficacy study of naltrexone SR/bupropion SR versus placebo in overweight and obese adults participating in an intensive behavior modificatio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• Naltrexone SR/Bupropion SR (combination therapy) (naltrexone sustained-release / bupropion sustained-release)

Snippet

Sponsor: Orexigen Therapeutics, Inc | Conditions: Obesity, Overweight | Phase 3 | Status: COMPLETED | Results posted: 2014-11-21